Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $124.9200 (-2.66%) ($124.7300 - $129.0000) on Wed. Jul. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.71% (three month average) | RSI | 70 | Latest Price | $124.9200(-2.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 4.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -0.855% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.855% (StdDev 1.71%) | Hourly BBV | 0 () | Intraday Trend | -3.1% | | | |
|
5 Day Moving Average | $125.92(-0.79%) | 10 Day Moving Average | $124.03(0.72%) | 20 Day Moving Average | $119.42(4.61%) | To recent high | -4.2% | To recent low | 11.7% | Market Cap | $2.008b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |